Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control Novocure Ltd (NASDAQ: NVCR) Benzinga · Mar 25, 2022
Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor Response A new study published in the Journal of Clinical Investigation (JCI) finds treatment with Novocure Ltd's (NASDAQ: NVCR) Tumor Treating Fields (TTFields) mediated cell disruption Benzinga · Feb 24, 2022